Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Head and neck rhabdomyosarcoma with TFCP2 fusions and ALK overexpression: a clinicopathological and molecular analysis of 11 cases

Histopathology(2020)10.1111/his.14323Source: DataRank Database

Head and neck rhabdomyosarcoma with TFCP2 fusions and ALK overexpression: a clinicopathological and molecular analysis of 11 cases is a research paper published in Histopathology (2020). On theSindex it has a DataRank of 0. It has been cited 92 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access92 citations

Download PDF

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 6.03)OA: greenTopics (86)Linked Datasets (6)DataCite Reuse (6)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Albert J.H. Suurmeijer ORCID,Narasimhan P. Agaram ORCID,Lei Zhang ORCID,Cristina R. Antonescu ORCID,Bin Xu ORCID

Live enrichment

PubMed:33382123 PMC:PMC8243398 OpenAlex:https://openalex.org/W3117551768

National Cancer Institute

Grant: P30CA008748

National Cancer Institute

Grant: P50 CA140146

National Cancer Institute

Grant: P50 CA217694

National Institutes of Health

Grant: 5P50CA140146-04

Administrative Core

National Institutes of Health

Grant: 2P30CA008748-43

MOUSE GENETICS

National Institutes of Health

Grant: 5P50CA217694-04

SPORE in Soft Tissue Sarcoma

Cycle for Survival

FWCI

6.03

Citation Percentile

1.0%

Citation Trend

2021

2022

2023

2024

2025

2026

greenLicense: other-oa

repositoryhttps://research.rug.nl/en/publications/b0df568a-4ced-4e4d-b325-1d42df4d3a69

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1111/his.14323

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1111/his.14323

journalhttps://doi.org/10.1111/his.14323

Fields of Study

Sarcoma Diagnosis and TreatmentCardiac tumors and thrombiCancer Genomics and Diagnostics0301 basic medicine03 medical and health sciences0302 clinical medicineAdolescentAdultAge FactorsAgedAnaplastic Lymphoma KinaseBiomarkers, TumorDNA-Binding ProteinsFemaleGenetic Predisposition to DiseaseHead and Neck NeoplasmsHumansIn Situ Hybridization, FluorescenceMaleMiddle AgedMyogeninOncogene Proteins, FusionPrognosisRNA-Binding Protein EWSRNA-Binding Protein FUSRhabdomyosarcomaSoft Tissue NeoplasmsTranscription FactorsYoung Adult

MeSH Terms

Anaplastic Lymphoma KinaseAdolescentAdultAge FactorsAgedDNA-Binding ProteinsFemaleHead and Neck NeoplasmsHumansMaleMiddle AgedPrognosisRhabdomyosarcomaSoft Tissue NeoplasmsTranscription FactorsBiomarkers, TumorOncogene Proteins, FusionIn Situ Hybridization, FluorescenceMyogeninGenetic Predisposition to DiseaseRNA-Binding Protein FUSRNA-Binding Protein EWSYoung Adult

Keywords

RhabdomyosarcomaHead and neckMedicinePathologySarcomaSurgeryalkEwsr1-tfcp2 FusionFus-tfcp2 FusionIntraosseous RhabdomyosarcomaAdultMaleAdolescentOncogene Proteins, FusionBiomarkers, TumorHumansAnaplastic Lymphoma KinaseGenetic Predisposition to DiseaseTRANSCRIPTIONRECURRENTIn Situ Hybridization, FluorescenceAgedFUS&#8211TFCP2 fusionAge FactorsMiddle AgedPrognosisDNA-Binding ProteinsHead and Neck NeoplasmsRNA-Binding Protein FUSFemaleMyogeninRNA-Binding Protein EWSEWSR1&#8211

Sustainable Development Goals

SDG 3: 3. Good health

Additional file 2 of Epithelioid and spindle rhabdomyosarcoma with TFCP2 rearrangement in abdominal wall: a distinctive entity with poor prognosis

10.6084/m9.figshare.22622432.v1figshare

Additional file 2 of Epithelioid and spindle rhabdomyosarcoma with TFCP2 rearrangement in abdominal wall: a distinctive entity with poor prognosis

10.6084/m9.figshare.22622432figshare

Additional file 3 of Epithelioid and spindle rhabdomyosarcoma with TFCP2 rearrangement in abdominal wall: a distinctive entity with poor prognosis

10.6084/m9.figshare.22622435.v1figshare

Additional file 3 of Epithelioid and spindle rhabdomyosarcoma with TFCP2 rearrangement in abdominal wall: a distinctive entity with poor prognosis

10.6084/m9.figshare.22622435figshare

Additional file 1 of Epithelioid and spindle rhabdomyosarcoma with TFCP2 rearrangement in abdominal wall: a distinctive entity with poor prognosis

10.6084/m9.figshare.22622429figshare